Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | PYGB | P11216 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | OGA | O60502 | 2/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.37 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.37 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HEXA | P06865 | 1/20 | 0.36 |
| ▸ | HEXB | P07686 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23848867 | 0.89 | PYGB (0.44) | GLAPYGBGAAOGALGALS1 | |
| SCHEMBL9621629 | 0.88 | OGA (0.42) | PYGBGAAOGAGBA1LGALS1 | |
| SCHEMBL12993503 | 0.86 | GBA1 (0.46) | PYGBGAAOGAGBA1LGALS1 | |
| SCHEMBL16644800 | 0.86 | GBA1 (0.46) | PYGBGAAOGAGBA1LGALS1 | |
| SCHEMBL16628196 | 0.86 | GBA1 (0.46) | PYGBGAAOGAGBA1LGALS1 | |
| SCHEMBL23848882 | 0.86 | GBA1 (0.46) | PYGBGAAOGAGBA1LGALS1 | |
| SCHEMBL8347365 | 0.86 | GBA1 (0.46) | PYGBGAAOGAGBA1LGALS1 | |
| SCHEMBL14028866 | 0.86 | GBA1 (0.46) | PYGBGAAOGAGBA1LGALS1 | |
| SCHEMBL18051737 | 0.81 | GBA1 (0.46) | PYGBGAAGBA1LGALS1LGALS3 | |
| SCHEMBL13957969 | 0.80 | LGALS1 (0.42) | PYGBGAAOGALGALS1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021188586-A1 | METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE MONOSACCHARIDES AND ANALOGS THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-09-23 | — | — | WO | disclosed |
| EP-3492477-A1 | BORON-CONTAINING COMPOUND | Stella Pharma Corporation (JP) | 2019-06-05 | — | — | EP | disclosed |